References
- 1. Allam JP, Paus T, Reichel C, Bieber T, Novak N. DRESS syndrome associated with carbamazepine and phenytoin. Eur J Dermatol. 2004;14(5):339–42.
- 2. Seth D, Kamat D, Montejo J. DRESS syndrome: a practical approach for primary care practitioners. Clin Pediatr. 2008;47(9):947–52.
- 3. Buck ML. DRESS syndrome: examples from the pediatric literature. Pediatr Pharm. 2012;18(11).
- 4. Vittorio CC, Muglia JJ. Anticonvulsant hypersensitivity syndrome. Arch Intern Med. 1995;155(21):2285-90.
- 5. Tennis P, Stern RS. Risk of serious cutaneous disorders after initiation of use of phenytoin, carbamazepine or sodium valproate: a record linkage study. Neurology. 1997;49(2):542-6.
- 6. Bocquet H, Bagot M, Roujeau JC. Drug-induced pseudolymphoma and drug hypersensitivity (Drug rash with eosinophilia and systemic symptoms: DRESS). Semin Cutan Med Surg. 1996;15(4):250–7.
- 7. Criado PR, Criado RF, Avancini JM, Santi CG. Drug reaction with eosinophilia and systemic symptoms (DRESS)/drug-induced hypersensitivity syndrome (DIHS): a review of current concepts. An Bras Dermatol. 2012;87(3):435–49.
- 8. Lee JY, Seol YJ, Shin DW, Kim DY, Chun HW, Kim BY, et al. A case of the Drug Reaction with Eosinophilia and Systemic Synptom (DRESS) following isoniazid treatment. Tuberc Respir Dis (Seoul). 2015;78(1):27–30.
- 9. Choudhary S, McLeod M, Torchia D, Romanelli P. Drug reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome. J Clin Aesthet Dermatol. 2013;6(6):31–7.
- 10. Ganeva M, Gancheva T, Lazarova R, Troeva J, Baldaranov I, Vassilev I, et al. Carbamazepine-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: report of four cases and brief review. Int J Dermatol. 2008;47(8):853-60.
- 11. Hung SI, Chung WH, Liou LB, Chu CC, Lin M, Huang HP, et al. HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol. Proc Natl Acad Sci USA. 2005;102(11):4134–9.
- 12. Kennebeck GA. Anticonvulsant hypersensitivity syndrome. J Am Board Fam Pract. 2000:13(5):364-70.
- 13. Peyriere H, Dereure O, Breton H, Demoly P, Cociglio M, Blayac JP, et al. Variability in the clinical pattern of cutaneous side effects of drugs with systemic symptoms: does a DRESS syndrome really exist? Br J Dermatol. 2006;155(2):422-8.
- 14. Mansur AT, Pekcan Yasar S, Goktay F. Anticonvulsant hypersensitivity syndrome: clinical and laboratory features. Int J Dermatol. 2008;47(11):1184-9.
- 15. Goodwin G, Consensus Group of the British Association for Psychopharmacology. Evidence-based guidelines for treating bipolar disorder: recommendations from the British Association for Psychopharmacology. J Psychopharmacol. 2003;17(2):149-73.
- 16. Ruble J, Matsuo F. Anticonvulsant-induced cutaneous reactions. Incidence, mechanisms and management. CNS Drugs. 1999;12(3):215-36.
- 17. Valencak J, Ortiz-Urda S, Heere-Ress E, Kunstfeld R, Base W. Carbamazepine-induced DRESS syndrome with recurrent fever ant exanthema. Int J Dermatol. 2004;43(1):51-4.